Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tract

Mucosal Immunology

Volumn 10, Issue 5, 2017, Pages 1259-1269

  Posavad, C M ^a,b   Zhao, L ^b   Dong, L ^b   Jin, L ^b   Stevens, C E ^b   Magaret, A S ^a,b   Johnston, C ^a,b   Wald, A ^a,b   Zhu, J ^a,b   Corey, L ^a,b   Koelle, D M ^a,b,c  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CD45RA ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR7; HERPES SIMPLEX VACCINE; ALPHA E INTEGRINS; ALPHA INTEGRIN; INTERLEUKIN 2; LEUKOCYTE ANTIGEN;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENRICHMENT CULTURE; EX VIVO STUDY; FEMALE; FEMALE GENITAL SYSTEM; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN TISSUE; MEMORY T LYMPHOCYTE; MUCOSA CELL; MUCOSAL IMMUNITY; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE SPECIFICITY; UTERINE CERVIX BIOPSY; CELL CULTURE; GENITAL HERPES; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INTRAEPITHELIAL LYMPHOCYTE; METABOLISM; MIDDLE AGED; MUCOSA; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; GENITALIA, FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOLOGIC MEMORY; INTEGRIN ALPHA CHAINS; INTERLEUKIN-2; INTRAEPITHELIAL LYMPHOCYTES; MIDDLE AGED; MUCOUS MEMBRANE; YOUNG ADULT;

EID: 85027981382     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.118     Document Type: Article

References (48)

1. Freeman, E.E., Weiss, H.A., Glynn, J.R., Cross, P.L., Whitworth, J.A. & Hayes, R.J. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20, 73-83 (2006).
2. Johnston, C. et al. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials. Lancet 379, 641-647 (2012).
3. Johnston, C., Koelle, D.M. & Wald, A. Current status and prospects for development of an HSV vaccine. Vaccine 32, 1553-1560 (2014).
4. Hofstetter, A.M., Rosenthal, S.L. & Stanberry, L.R. Current thinking on genital herpes. Curr. Opin. Infect. Dis 27, 75-83 (2014).
5. Wald, A. et al. Therapeutic HSV-2 Vaccine (GEN003) Results in Durable Reduction in Genital Lesions at 1 Year. Open Forum Infectious Diseases 1, S1-S65 (2014).
6. Schenkel, J.M. & Masopust, D. Tissue-resident memory Tcells. Immunity 41, 886-897 (2014).
7. Iijima, N. & Iwasaki, A. Tissue instruction for migration and retention of TRM cells. Trends Immunol. 36, 556-564 (2015).
8. Carbone, F.R. Tissue-resident memory T cells and fixed immune surveillance in nonlymphoid organs. J. Immunol. 195, 17-22 (2015).
9. Parr, M.B. & Parr, E.L. Intravaginal administration of herpes simplex virus type 2 to mice leads to infection of several neural and extraneural sites. J. Neurovirol. 9, 594-602 (2003).
10. Khoury-Hanold,W. et al. Viral spreadtoenteric neurons links genital HSV-1 infection to toxic megacolon and lethality. Cell Host Microbe 19, 788-799 (2016).
11. Tronstein, E. et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 305, 1441-1449 (2011).
12. Ouwendijk, W.J., Laing, K.J., Verjans, G.M. & Koelle, D.M. T-cell immunity to human alphaherpesviruses. Curr. Opin. Virol 3, 452-460 (2013).
13. Koelle, D.M., Schomogyi, M. & Corey, L. Antigen-specific Tcells localize to the uterine cervix in women with genital herpes simplex virus type 2 infection. J. Infect. Dis. 182, 662-670 (2000).
14. Posavad, C.M. et al. Persistence of mucosal T-cell responses to herpes simplex virus type 2 in the female genital tract. Mucosal Immunol 8, 115-126 (2015).
15. Geginat, J., Lanzavecchia, A. & Sallusto, F. Proliferation and differentiation potential of human CD8+ memory T-cell subsets inresponse to antigen or homeostatic cytokines. Blood 101, 4260-4266 (2003).
16. Mackay, L.K. et al. Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention. J. Immunol. 194, 2059-2063 (2015).
17. Hadley, G.A. & Higgins, J.M. Integrin alphaEbeta7: molecular features and functional significance in the immune system. Adv. Exp. Med. Biol. 819, 97-110 (2014).
18. Watanabe, R. et al. Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculatingmemory T cells. Sci. Transl. Med. 7, 279ra39 (2015).
19. Horton, H. et al. Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific Tcells induced by vaccination. J. Immunol. Methods 323, 39-54 (2007).
20. McKinnon, L.R.et al. Optimizing viable leukocyte sampling from the female genital tract for clinical trials: an international multi-site study. PLoS One 9, e85675 (2014).
21. Thome, J.J. et al. Spatial map of human Tcell compartmentalization and maintenance over decades of life. Cell 159, 814-828 (2014).
22. Autengruber, A.,Gereke, M., Hansen, G.,Hennig,C.&Bruder,D.Impact of enzymatic tissue disintegration on the level of surface molecule expression and immune cell function. Eur. J. Microbiol. Immunol. 2, 112-120 (2012).
23. He, X., de Oliveira, V.L., Keijsers, R., Joosten, I. & Koenen, H.J. Lymphocyte isolation from human skin for phenotypic analysis and ex vivo cell culture. J. Vis. Exp. 110, e52564 (2016).
24. Nkwanyana, N.N. et al. Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cellsinthe female genital tract. Immunology 128, e746-e757 (2009).
25. Sathaliyawala, T. et al. Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity 38, 187-197 (2013).
26. Jing, L. et al. Extensive CD4 and CD8 T cell cross-reactivity between alphaherpesviruses. J. Immunol. 196, 2205-2218 (2016).
27. Zhu, J. et al. Immune surveillance by CD8alphaalpha+ skin-resident T cells in human herpes virus infection. Nature 497, 494-497 (2013).
28. Turner, D.L. & Farber, D.L. Mucosal resident memory CD4 T cells in protection and immunopathology. Front. Immunol 5, 331 (2014).
29. Teijaro, J.R., Turner, D., Pham, Q., Wherry, E.J., Lefrancois, L. & Farber, D.L. Cutting edge: tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J. Immunol. 187, 5510-5514 (2011).
30. Nakanishi, Y., Lu, B., Gerard, C. & Iwasaki, A. CD8(+ ) T lymphocyte mobilization to virus-infected tissue requires CD4( + ) T-cell help. Nature 462, 510-513 (2009).
31. Laidlaw, B.J. et al. CD4 + Tcell help guides formation of CD103 + lung-resident memory CD8 + T cells during influenza viral infection. Immunity 41, 633-645 (2014).
32. Stary, G. et al. VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science 348, aaa8205 (2015).
33. Iijima, N. & Iwasaki, A. T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory CD4 Tcells. Science 346, 93-98 (2014).
34. Moss, N.J. et al. Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes. J. Virol. 86, 9952-9963 (2012).
35. Paavonen, J. et al. Colposcopic manifestations of cervical and vaginal infections. Obst. Gynec. Survey 43, 373-381 (1988).
36. Tanton, C. et al. Patterns of herpes simplex virus shedding over 1 month and the impact of acyclovir and HIV in HSV-2-seropositive women in Tanzania. Sex. Transm. Infect. 87, 406-411 (2011).
37. Eggert-Kruse, W., Mildenberger-Sandbrink, B., Schnitzler, P., Rohr, G., Strowitzki, T. & Petzoldt, D. Herpes simplex virus infection of the uterine cervix-relationship with a cervical factor?. Fertility and Sterility 73, 248-257 (2000).
38. Aumakhan, B. et al. Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data. Virol. J. 7, 328 (2010).
39. Johnston, C. et al. Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection. J. Virol. 88, 4921-4931 (2014).
40. Abdool Karim, S.S. et al. Tenofovir gel for the prevention of herpes simplex virus type 2 infection. N. Engl. J. Med. 373, 530-539 (2015).
41. Hladik, F. et al. Mucosal effects of tenofovir 1% gel. Elife 4, e04525 (2015).
42. Morrow, R.A. & Friedrich, D. Inaccuracy of certain commercial enzyme immunoassays in diagnosing genital infections with herpes simplex virus types 1 or 2. Am. J. Clin. Pathol 120, 839-844 (2003).
43. Morrow, R.A., Friedrich, D., Meier, A. & Corey, L. Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA. BMC Infect. Dis. 5, 84 (2005).
44. John, M. et al. Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection. J. Infect. Dis. 192, 1731-1740 (2005).
45. Bull, M. et al. Defining blood processingparametersfor optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J. Immunol. Methods 322, 57-69 (2007).
46. Hosken, N. et al. Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes. J. Virol. 80, 5509-5515 (2006).
47. Posavad, C.M. et al. Detailed characterization of Tcell responsesto herpes simplex virus-2 in immune seronegative persons. J. Immunol. 184, 3250-3259 (2010).
48. Jerome, K.R., Huang, M.L., Wald, A., Selke, S. & Corey, L. Quantitative stability ofDNA after extended storageof clinical specimensas determined by real-time PCR. J. Clin. Microbiol. 40, 2609-2611 (2002).